ARIPIPRAZOLE
| Brand name | OPIPZA |
|---|---|
| Active ingredient | ARIPIPRAZOLE |
| Strength | 10MG |
| Dosage form | FILM |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2024 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11701352 | December 2041 | product |
| 11331315 | November 2040 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.